HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLOUDBREAK-B

1.190

0.000

Volume:- -

Turnover:- -

Market Cap:1.10B

PE:-11.55

High:1.190

Open:1.190

Low:1.190

Close:1.190

52wk High:9.580

52wk Low:0.900

Shares:925.00M

HK Float Shares:925.00M

Volume Ratio:0.37

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.103

ROE:--

ROA:-190.68%

PB:3.34

PE(LYR):-11.55

PS:521.49

Loading ...

Overview Company News Filings

Cloudbreak Pharma Inc. - Did not Recommend the Payment of an Interim Dividend

THOMSON REUTERS

Cloudbreak Pharma Schedules 31 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend

Bulletin Express

Cloudbreak Pharma Sets Board Meeting to Review Interim Results, Consider Dividend

Cloudbreak Pharma Files HKEX Next-day Disclosure Return, Share Capital Rises by 41.7 Million Shares

We're Keeping An Eye On Cloudbreak Pharma's (HKG:2592) Cash Burn Rate

Simply Wall St.

Cloudbreak Pharma Appoints New Company Secretary and Authorised Representative

Bulletin Express

Cloudbreak Pharma: FDA Clears IND Safety Review for Dry-Eye Candidate CBT-358

Bulletin Express

CLOUDBREAK-B Receives FDA Clearance for Safety Review of CBT-358 Investigational New Drug Application

Cloudbreak Pharma - FDA Completes Safety Review of Cbt-358 Ind Application with no Objection

THOMSON REUTERS

Cloudbreak Pharma Names Tsang Ngo Yin Company Secretary, Authorized Representative After Fung Nga Fong Exit

Cloudbreak-B Initiates Discounted ATM Offering Amid Clinical Milestones, Yet Losses and Cash Burn Persist, Shares Down Over 80% Since IPO

Cloudbreak Pharma Files HKEX Next-day Disclosure Return, Lifts Share Capital by 22,848,000 Shares

Cloudbreak Pharma Adopts AGM Resolutions by Shareholder Vote

Cloudbreak Pharma survey shows pinguecula patients report high burden, strong interest in prescription treatment

Cloudbreak-B Announces Proposed Issuance of Subscription Shares to Abraham Dominguez Cinta

CLOUDBREAK-B Announces Proposed Share Subscription to Abraham Dominguez Cinta

Cloudbreak Pharma to Raise up to US$15.00 Million via Share Subscription with ARC Group

Bulletin Express

Cloudbreak Pharma - Enters Share Subscription Agreement With ARC Group International for up to $15 Mln

THOMSON REUTERS

Cloudbreak Pharma signs share subscription deal for up to US$15 million with ARC Group unit

CLOUDBREAK-B Issues 5.712 Million Shares Under Equity Incentive Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/02592/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02592","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","market":"HK","secType":"STK","nameCN":"CLOUDBREAK-B","latestPrice":1.19,"timestamp":1790731215206,"preClose":1.19,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":925000000,"shares":925000000,"eps":-0.103023,"marketStatus":"Halted","change":0,"latestTime":"09-30 09:20:15","open":1.19,"high":1.19,"low":1.19,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.024,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1751472000000,"exchange":"SEHK","adjPreClose":1.19,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":0.369999998816,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02592\",,,,,undefined,":{"symbol":"02592","floatShares":925000000,"roa":"-190.68%","roe":"--","lyrEps":-0.103023,"volumeRatio":0.369999998816,"shares":925000000,"dividePrice":0,"high":1.19,"amplitude":0,"preClose":1.19,"low":1.19,"week52Low":0.9,"pbRate":"3.34","psRate":"521.49","week52High":9.58,"institutionHeld":0,"latestPrice":1.19,"eps":-0.103023,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.024,"open":1.19,"prevYearClose":5.2,"prevWeekClose":1.19,"prevMonthClose":1.19,"prevQuarterClose":1.19,"fiveDayClose":1.19,"twentyDayClose":1.155,"sixtyDayClose":1.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02592\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"02592","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02592\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02592\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02592\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02592","date":"2026-09-30","current":-1.162109,"percent":0.938111,"low":-24.505522,"twenty":-11.783096,"median":-5.517226,"eighty":-1.950052,"high":-1.021022,"avg":-6.302294,"sd":4.961874,"marketCap":1100383856},"quantilePoints":[{"date":"2025-07-04","current":-6.317277,"twenty":-6.610502,"median":-6.500542,"eighty":-6.390583,"marketCap":4915912241},{"date":"2025-07-11","current":-6.166376,"twenty":-6.470405,"median":-6.317277,"eighty":-6.263403,"marketCap":4798467239},{"date":"2025-07-18","current":-6.350904,"twenty":-6.498689,"median":-6.350281,"eighty":-6.263403,"marketCap":4941079027},{"date":"2025-07-25","current":-6.080141,"twenty":-6.48004,"median":-6.306537,"eighty":-6.134066,"marketCap":4731355809},{"date":"2025-08-01","current":-5.497985,"twenty":-6.418895,"median":-6.177156,"eighty":-6.011186,"marketCap":4278353657},{"date":"2025-08-08","current":-5.49809,"twenty":-6.350655,"median":-6.13405,"eighty":-5.65539,"marketCap":4278353657},{"date":"2025-08-15","current":-5.725306,"twenty":-6.343182,"median":-6.058573,"eighty":-5.554248,"marketCap":4446132232},{"date":"2025-08-22","current":-5.53457,"twenty":-6.315129,"median":-6.004685,"eighty":-5.554248,"marketCap":4286742586},{"date":"2025-08-29","current":-5.503941,"twenty":-6.295753,"median":-5.870846,"eighty":-5.538055,"marketCap":4253186871},{"date":"2025-09-05","current":-5.413205,"twenty":-6.239682,"median":-5.742284,"eighty":-5.49926,"marketCap":4186075441},{"date":"2025-09-12","current":-12.640894,"twenty":-6.350655,"median":-5.870846,"eighty":-5.508123,"marketCap":4118964011},{"date":"2025-09-19","current":-12.711577,"twenty":-6.612702,"median":-6.004685,"eighty":-5.525012,"marketCap":4135741868},{"date":"2025-09-26","current":-11.804503,"twenty":-12.358821,"median":-6.058573,"eighty":-5.527436,"marketCap":3842129362},{"date":"2025-10-03","current":-6.439136,"twenty":-12.191113,"median":-6.134046,"eighty":-5.53457,"marketCap":2096453591},{"date":"2025-10-10","current":-5.988337,"twenty":-11.881825,"median":-6.134089,"eighty":-5.548508,"marketCap":1949083838},{"date":"2025-10-17","current":-12.3346,"twenty":-12.21981,"median":-6.187936,"eighty":-5.561014,"marketCap":4009907937},{"date":"2025-10-24","current":-11.844495,"twenty":-12.25273,"median":-6.279578,"eighty":-5.580054,"marketCap":3850518291},{"date":"2025-10-31","current":-12.15705,"twenty":-12.335851,"median":-6.333467,"eighty":-5.585568,"marketCap":3951185436},{"date":"2025-11-07","current":-11.838569,"twenty":-12.273198,"median":-6.424535,"eighty":-5.601607,"marketCap":3850518291},{"date":"2025-11-14","current":-11.510378,"twenty":-12.207573,"median":-6.465107,"eighty":-5.621104,"marketCap":3741462218},{"date":"2025-11-21","current":-12.23865,"twenty":-12.234818,"median":-6.500592,"eighty":-5.630174,"marketCap":3984741151},{"date":"2025-11-28","current":-21.343443,"twenty":-12.412307,"median":-6.613869,"eighty":-5.677994,"marketCap":6946032996},{"date":"2025-12-05","current":-20.614529,"twenty":-12.626633,"median":-6.790202,"eighty":-5.718633,"marketCap":6711142992},{"date":"2025-12-12","current":-17.961539,"twenty":-12.716498,"median":-11.142834,"eighty":-5.735493,"marketCap":5847083331},{"date":"2025-12-19","current":-14.819321,"twenty":-12.837409,"median":-11.27102,"eighty":-5.75741,"marketCap":4823634025},{"date":"2025-12-24","current":-14.055026,"twenty":-12.984934,"median":-11.600706,"eighty":-5.767869,"marketCap":4571966163},{"date":"2026-01-02","current":-11.620216,"twenty":-12.995771,"median":-11.729724,"eighty":-5.769371,"marketCap":3783406861},{"date":"2026-01-09","current":-7.540769,"twenty":-12.961935,"median":-11.510378,"eighty":-5.972321,"marketCap":2457956120},{"date":"2026-01-16","current":-8.049692,"twenty":-12.941587,"median":-11.169175,"eighty":-5.988337,"marketCap":2625734695},{"date":"2026-01-23","current":-6.609576,"twenty":-12.863288,"median":-10.620058,"eighty":-5.996682,"marketCap":2155954686},{"date":"2026-01-30","current":-6.294491,"twenty":-12.820156,"median":-9.452561,"eighty":-6.004685,"marketCap":2055287541},{"date":"2026-02-06","current":-5.800172,"twenty":-12.797534,"median":-8.075865,"eighty":-6.004685,"marketCap":1895897895},{"date":"2026-02-13","current":-5.772062,"twenty":-12.788929,"median":-7.957902,"eighty":-5.976779,"marketCap":1887508966},{"date":"2026-02-20","current":-5.722622,"twenty":-12.762909,"median":-7.89408,"eighty":-5.899654,"marketCap":1870731109},{"date":"2026-02-27","current":-5.716309,"twenty":-12.718958,"median":-7.540769,"eighty":-5.819712,"marketCap":1870731109},{"date":"2026-03-06","current":-5.592845,"twenty":-12.7039,"median":-6.802294,"eighty":-5.77076,"marketCap":1828786465},{"date":"2026-03-13","current":-5.252211,"twenty":-12.674344,"median":-6.763399,"eighty":-5.752368,"marketCap":1719730391},{"date":"2026-03-20","current":-4.787506,"twenty":-12.644727,"median":-6.625153,"eighty":-5.711698,"marketCap":1568729674},{"date":"2026-03-27","current":-4.279308,"twenty":-12.631386,"median":-6.530805,"eighty":-5.600393,"marketCap":1400951099},{"date":"2026-04-02","current":-4.3756,"twenty":-12.611231,"median":-6.512878,"eighty":-5.567465,"marketCap":1434506814},{"date":"2026-04-10","current":-4.248889,"twenty":-12.593551,"median":-6.499576,"eighty":-5.532786,"marketCap":1392562170},{"date":"2026-04-17","current":-3.434267,"twenty":-12.529717,"median":-6.439136,"eighty":-5.502771,"marketCap":1124116451},{"date":"2026-04-24","current":-3.028108,"twenty":-12.499065,"median":-6.412742,"eighty":-5.465751,"marketCap":1604675194},{"date":"2026-04-30","current":-2.35827,"twenty":-12.455796,"median":-6.350281,"eighty":-5.436669,"marketCap":1249957520},{"date":"2026-05-08","current":-2.422963,"twenty":-12.412307,"median":-6.306537,"eighty":-5.348441,"marketCap":1283740155},{"date":"2026-05-15","current":-2.215232,"twenty":-12.362936,"median":-6.237324,"eighty":-5.224545,"marketCap":1173946589},{"date":"2026-05-22","current":-2.103037,"twenty":-12.335851,"median":-6.187936,"eighty":-5.079251,"marketCap":1114826977},{"date":"2026-05-29","current":-2.055189,"twenty":-12.29622,"median":-6.159956,"eighty":-4.693687,"marketCap":1089490000},{"date":"2026-06-05","current":-1.943602,"twenty":-12.236095,"median":-6.134636,"eighty":-4.452767,"marketCap":1030370388},{"date":"2026-06-12","current":-2.070618,"twenty":-12.215803,"median":-6.134042,"eighty":-4.302022,"marketCap":1097935659},{"date":"2026-06-18","current":-1.863414,"twenty":-12.1843,"median":-6.080141,"eighty":-4.208883,"marketCap":988142093},{"date":"2026-06-26","current":-1.607919,"twenty":-12.150518,"median":-6.004708,"eighty":-3.379693,"marketCap":853011550},{"date":"2026-07-03","current":-2.053171,"twenty":-12.124388,"median":-5.992509,"eighty":-2.739542,"marketCap":1089490000},{"date":"2026-07-10","current":-2.134398,"twenty":-12.109822,"median":-5.972321,"eighty":-2.532616,"marketCap":1131718295},{"date":"2026-07-17","current":-2.101828,"twenty":-11.973906,"median":-5.886479,"eighty":-2.422963,"marketCap":1114826977},{"date":"2026-07-24","current":-2.069578,"twenty":-11.968515,"median":-5.84391,"eighty":-2.309668,"marketCap":1097935659},{"date":"2026-07-31","current":-1.862057,"twenty":-11.947093,"median":-5.798666,"eighty":-2.247923,"marketCap":988142093},{"date":"2026-08-07","current":-1.925288,"twenty":-11.910048,"median":-5.770977,"eighty":-2.212119,"marketCap":1021924729},{"date":"2026-08-14","current":-1.869116,"twenty":-11.882099,"median":-5.767494,"eighty":-2.165101,"marketCap":992364923},{"date":"2026-08-21","current":-1.909914,"twenty":-11.871403,"median":-5.723964,"eighty":-2.134253,"marketCap":1013479070},{"date":"2026-08-28","current":-1.839188,"twenty":-11.868929,"median":-5.708624,"eighty":-2.114609,"marketCap":975473605},{"date":"2026-09-04","current":-1.052314,"twenty":-11.849329,"median":-5.61954,"eighty":-2.086117,"marketCap":996587752},{"date":"2026-09-11","current":-1.061097,"twenty":-11.839754,"median":-5.586446,"eighty":-2.054785,"marketCap":1005033411},{"date":"2026-09-18","current":-1.060471,"twenty":-11.811316,"median":-5.557631,"eighty":-2.022819,"marketCap":1005033411},{"date":"2026-09-25","current":-1.060898,"twenty":-11.795209,"median":-5.525652,"eighty":-1.987309,"marketCap":1005033411},{"date":"2026-09-30","current":-1.160924,"twenty":-11.783096,"median":-5.517226,"eighty":-1.950052,"marketCap":1100383856}],"updateTime":1790832028100},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02592\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663740640","title":"Cloudbreak Pharma Inc. - Did not Recommend the Payment of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663740640","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663740640?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:37","pubTimestamp":1788172656,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44S063:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130257316","title":"Cloudbreak Pharma Schedules 31 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1130257316","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130257316?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:28","pubTimestamp":1787149739,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. has announced that its board of directors will convene on 31 August 2026 to review and approve the Group’s unaudited interim results for the six months ended 30 June 2026. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429842","title":"Cloudbreak Pharma Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429842","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429842?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:13","pubTimestamp":1787148804,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma sets board meeting to review interim results, consider dividendCloudbreak Pharma will hold a board meeting on Aug. 31, 2026 to review unaudited interim results for the six months end","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL3jHvLn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656179053","title":"Cloudbreak Pharma Files HKEX Next-day Disclosure Return, Share Capital Rises by 41.7 Million Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656179053","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656179053?lang=en_us&edition=fundamental","pubTime":"2026-08-02 18:28","pubTimestamp":1785666534,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma files HKEX next-day disclosure return, share capital rises by 41.7 million sharesCloudbreak Pharma filed a next-day disclosure return covering share issuances on July 31 under incent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260802:nNDL62VlWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656314281","title":"We're Keeping An Eye On Cloudbreak Pharma's (HKG:2592) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656314281","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656314281?lang=en_us&edition=fundamental","pubTime":"2026-08-02 09:09","pubTimestamp":1785632981,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2592/cloudbreak-pharma-shares/news/were-keeping-an-eye-on-cloudbreak-pharmas-hkg2592-cash-burn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2592/cloudbreak-pharma-shares/news/were-keeping-an-eye-on-cloudbreak-pharmas-hkg2592-cash-burn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133013404","title":"Cloudbreak Pharma Appoints New Company Secretary and Authorised Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1133013404","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133013404?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:44","pubTimestamp":1784285044,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. announced that, effective 17 July 2026, Ms. Fung Nga Fong has resigned from her roles as Company Secretary and Authorised Representative under both the Hong Kong Listing Rules...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140542229","title":"Cloudbreak Pharma: FDA Clears IND Safety Review for Dry-Eye Candidate CBT-358","url":"https://stock-news.laohu8.com/highlight/detail?id=1140542229","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140542229?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:43","pubTimestamp":1784285039,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. (CLOUDBREAK-B) reported that the U.S. Food and Drug Administration completed its safety review of the investigational new drug (IND) application for CBT-358 on 14 July 2026...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155527014","title":"CLOUDBREAK-B Receives FDA Clearance for Safety Review of CBT-358 Investigational New Drug Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1155527014","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155527014?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:42","pubTimestamp":1784284941,"startTime":"0","endTime":"0","summary":"CLOUDBREAK-B (ASX: 02592) has announced the completion of the review period concerning the Investigational New Drug (IND) application for CBT-358, which was submitted to the U.S. Food and Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBT","BMED","BK4090","BK1161","02592","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652402226","title":"Cloudbreak Pharma - FDA Completes Safety Review of Cbt-358 Ind Application with no Objection","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402226","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652402226?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:39","pubTimestamp":1784284756,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43J0EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652402188","title":"Cloudbreak Pharma Names Tsang Ngo Yin Company Secretary, Authorized Representative After Fung Nga Fong Exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2652402188","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652402188?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:30","pubTimestamp":1784284228,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma names Tsang Ngo Yin company secretary, authorized representative after Fung Nga Fong exitCloudbreak Pharma named Tsang Ngo Yin as company secretary, effective July 17, 2026, replacing Fung Nga Fong, who resigned.Tsang brings 20+ years in regulatory compliance, corporate finance, company secretarial work, internal control, auditing, financial management.Tsang holds a BBA from Simon Fraser University, an LLB from Tsinghua University, an LLM from the University of Wolverhampton.She is a member of the AICPA, the HKICPA, currently serves as company secretary of HG Semiconductor .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cloudbreak Pharma Inc. published the original content used to generate this news brief via IIS, the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL24TNYp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592","06908","BK1163","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169608073","title":"Cloudbreak-B Initiates Discounted ATM Offering Amid Clinical Milestones, Yet Losses and Cash Burn Persist, Shares Down Over 80% Since IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1169608073","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169608073?lang=en_us&edition=fundamental","pubTime":"2026-07-02 20:51","pubTimestamp":1782996676,"startTime":"0","endTime":"0","summary":"Since its listing on the Hong Kong Stock Exchange in July 2025, Cloudbreak-B (02592.HK), a company once hailed as a star in innovative ophthalmic drugs, has seen disappointing stock performance....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","159399","BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536666","title":"Cloudbreak Pharma Files HKEX Next-day Disclosure Return, Lifts Share Capital by 22,848,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536666","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647536666?lang=en_us&edition=fundamental","pubTime":"2026-06-30 16:42","pubTimestamp":1782808935,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma files HKEX next-day disclosure return, lifts share capital by 22,848,000 sharesCloudbreak Pharma filed a next-day disclosure return on June 30, 2026 covering an increase in issued shares.Issued 22,848,000 new ordinary shares under its 2023 Equity Incentive Scheme at HKD 0 per share.Issued shares rose 2.66% to 880,467,081 from 857,619,081; treasury shares stayed at 0.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cloudbreak Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDLbnJ13Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646089350","title":"Cloudbreak Pharma Adopts AGM Resolutions by Shareholder Vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2646089350","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646089350?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:27","pubTimestamp":1782480476,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma adopts AGM resolutions by shareholder voteShareholders met on June 26, 2026.Adopted the audited financial statements for the year ended Dec. 31, 2025, alongside the directors’ and au","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL191XKK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024681","title":"Cloudbreak Pharma survey shows pinguecula patients report high burden, strong interest in prescription treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024681","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024681?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:00","pubTimestamp":1782129658,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma released results from an April–May 2026 U.S. patient survey on pinguecula; full findings are slated for a peer-reviewed journal.Survey indicates the condition is widely viewed as bothersome, with symptoms reported to disrupt daily comfort and quality of life.Responses suggest meaningful demand for a prescription treatment despite no FDA-approved drug specifically for pinguecula.Management positioned the survey as commercial and clinical support for CBT-004, following earlier Phase 2 results it described as encouraging.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDLb5h4H7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157202204","title":"Cloudbreak-B Announces Proposed Issuance of Subscription Shares to Abraham Dominguez Cinta","url":"https://stock-news.laohu8.com/highlight/detail?id=1157202204","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157202204?lang=en_us&edition=fundamental","pubTime":"2026-06-22 08:30","pubTimestamp":1782088252,"startTime":"0","endTime":"0","summary":" CLOUDBREAK-B (ASX: 02592) has announced that on June 18, 2026, following trading hours, the company entered into a share subscription agreement with investor ARC Group International Limited.Under...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156269895","title":"CLOUDBREAK-B Announces Proposed Share Subscription to Abraham Dominguez Cinta","url":"https://stock-news.laohu8.com/highlight/detail?id=1156269895","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156269895?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:08","pubTimestamp":1781795290,"startTime":"0","endTime":"0","summary":"CLOUDBREAK-B (02592) has disclosed an agreement to issue new shares to an investor.On June 18, 2026, following market close, the company entered into a share subscription pact with investor ARC Group...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193630343","title":"Cloudbreak Pharma to Raise up to US$15.00 Million via Share Subscription with ARC Group","url":"https://stock-news.laohu8.com/highlight/detail?id=1193630343","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193630343?lang=en_us&edition=fundamental","pubTime":"2026-06-18 23:05","pubTimestamp":1781795128,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma Inc. (CLOUDBREAK-B, 02592) has signed a Share Subscription Agreement with ARC Group International Ltd. that entitles the investor to subscribe for new shares worth up to US$15.00...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084213","title":"Cloudbreak Pharma - Enters Share Subscription Agreement With ARC Group International for up to $15 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644084213?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:51","pubTimestamp":1781794276,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nFWN42Q0TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644084210","title":"Cloudbreak Pharma signs share subscription deal for up to US$15 million with ARC Group unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2644084210","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644084210?lang=en_us&edition=fundamental","pubTime":"2026-06-18 22:51","pubTimestamp":1781794269,"startTime":"0","endTime":"0","summary":"Cloudbreak Pharma entered a share subscription deal for up to USD 15 million of new shares with ARC Group International.Issuance can occur in multiple drawdowns over 12 months, capped at 167,778,574 shares under an existing general mandate.Pricing set at 93% of average closing bid over a 15-day pricing period, subject to a floor of HKD 1.03.Maximum net proceeds estimated at USD 14.51 million, earmarked for R&D, PRC bank loan repayment, working capital.Commitment fee set at USD 0.3 million in cash, with 60% payable within five business days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cloudbreak Pharma Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong K","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL3Ch96D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02592"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113708786","title":"CLOUDBREAK-B Issues 5.712 Million Shares Under Equity Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1113708786","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113708786?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:38","pubTimestamp":1780994299,"startTime":"0","endTime":"0","summary":"CLOUDBREAK-B (02592) has announced the allotment and issuance of 5.712 million shares.The issuance was completed on June 9, 2026, in accordance with the company's 2023 equity incentive plan.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02592","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":63,"code":"91000000","status":"200"}]}}